Trade-margin caps make 137 cancer medicines cheaper
The National Pharmaceutical Pricing Authority (NPPA) has capped trade margins at 30% on 137 cancer medicines. Prices of many have fallen sharply from 9 November 2026. Read it to revise NPPA, the Drug Price Control Order and medicine affordability.
- Medicines covered
- 137 anti-cancer drugs
- Trade margin cap
- 30%
- Biggest price cut
- 96.45%
- Estimated savings
- ₹3,357.49 crore
Cancer drug prices: what happened?
Cancer can wipe out a family’s savings. Some of its medicines just became up to 96% cheaper.
- On 17 October 2026, NPPA capped the trade margin at 30% on 137 non-scheduled anti-cancer medicines, including patented ones.
- The cap takes effect from 9 November 2026.
- By 4 November, 70 companies had revised prices of 120 drugs.
- The biggest cut is 96.45%; most cuts are 20–70%.
- Patients are expected to save about ₹3,357.49 crore.
What is a trade margin?
A trade margin is the gap between what a company charges and what the patient pays. Distributors and chemists keep it.
For some cancer drugs, this gap was very large. Capping it brings the shop price (MRP) down.
‘Non-scheduled’ medicines are those outside the price-control list, so NPPA used special powers.
Cancer drug margin cap
| Item | Figure |
|---|---|
| Medicines | 137 |
| Companies that revised prices | 70 (120 drugs) |
| Biggest cut | 96.45% |
| Savings | ₹3,357.49 crore |
Which laws and Articles apply?
- Drugs (Prices Control) Order, 2013: sets ceiling prices for scheduled medicines.
- Paragraph 19 of DPCO 2013: lets government fix prices of any drug in public interest in special cases.
- Essential Commodities Act, 1955: DPCO is issued under it.
- National List of Essential Medicines (NLEM) 2022: the list of key medicines under price control.
Why does cancer drug price caps matter?
| Angle | What to note |
|---|---|
| Patients | Lower bills for long cancer treatment. |
| Equity | Poor families can finish treatment. |
| Regulation | Shows NPPA’s special powers. |
| Prelims | NPPA, DPCO, NLEM basics. |
What are the problems with cancer drug price caps?
- Companies may cut supply of low-margin drugs.
- Chemists may resist lower margins.
- Checking compliance at every shop is hard.
- Patented drug prices remain high.
What should be done next on cancer drug price caps?
- Watch for shortages after the cap.
- Expand Jan Aushadhi stores for cancer drugs.
- Publish price lists at hospitals.
- Review margins for other costly drug groups.
What can Prelims ask on cancer drug price caps?
Prelims probability: Medium–High — trade-margin cap and paragraph 19 are crisp; pricing body and essential-medicine list are testable static.
- NPPA set up in 1997.
- DPCO 2013 issued under the Essential Commodities Act.
- Paragraph 19 = special public-interest powers.
- Trade margin cap: 30%.
- NLEM 2022 lists essential medicines.
How to write about cancer drug price caps in Mains
Practice question (15 marks, 250 words): Capping trade margins is a quick way to make life-saving drugs affordable. Discuss with reference to NPPA’s move on cancer medicines.
- Intro: 137 drugs, 30% cap.
- Why margins were high.
- Legal tool: DPCO paragraph 19.
- Risks: supply, compliance.
- Conclusion: affordable cancer care.
Ready lines for your answer
- A cure is useless if the patient cannot afford it.
- Price control works only if the medicine stays on the shelf.
Quotable data pointMargins capped at 30% on 137 cancer drugs; savings about ₹3,357.49 crore.
Photo: Gowtham Sampath, CC BY-SA 4.0, via Wikimedia Commons
Exam angle
Prelims: NPPA, DPCO, NLEM. · Mains GS-II: health access and regulation.
Practice MCQs
Original practice questions (not PYQs).
The National Pharmaceutical Pricing Authority capped the trade margin on 137 non-scheduled anti-cancer medicines at:
Answer (c) & explanation
The 17 October 2026 order caps the trade margin at 30 percent of maximum retail price, effective 9 November 2026.
Estimated patient savings from the cancer medicine trade-margin cap were reported around:
Answer (c) & explanation
Press Information Bureau cited estimated savings of about ₹3,357.49 crore, with average maximum retail price cuts of 20 to 70 percent.
Questions students ask about this
What did NPPA do?
It capped trade margins at 30% on 137 cancer medicines.
From when?
From 9 November 2026.
How big are the cuts?
Up to 96.45%; most fall between 20% and 70%.
Under which rule?
Paragraph 19 of the Drugs (Prices Control) Order, 2013.